Inhibition of VCP preserves retinal structure and function in autosomal dominant retinal degeneration

Published on Nov 19, 2020in bioRxiv
· DOI :10.1101/2020.11.17.384669
Blanca Arango-Gonzalez18
Estimated H-index: 18
(University of Tübingen),
Merve Sen2
Estimated H-index: 2
(University of Tübingen)
+ 12 AuthorsMarius Ueffing72
Estimated H-index: 72
(University of Tübingen)
Sources
Abstract
Due to continuously high production rates of rhodopsin (RHO) and high metabolic activity, photoreceptor neurons are especially vulnerable to defects in proteostasis. A proline to histidine substitution at position 23 (P23H) leads to production of structurally misfolded RHO, causing the most common form of autosomal dominant Retinitis Pigmentosa (adRP) in North America. The AAA-ATPase valosin-containing protein (VCP) extracts misfolded proteins from the ER membrane for cytosolic degradation. Here, we provide the first evidence that inhibition of VCP activity rescues degenerating P23H rod cells and improves their functional properties in P23H transgenic rat and P23H knock-in mouse retinae, both in vitro and in vivo. This improvement correlates with the restoration of the physiological RHO localization to rod outer segments (OS) and properly-assembled OS disks. As a single intravitreal injection suffices to deliver a long-lasting benefit in vivo, we suggest VCP inhibition as a potential therapeutic strategy for adRP patients carrying mutations in the RHO gene.
References91
Newest
#1Feng Wang (Los Angeles Biomedical Research Institute)H-Index: 2
#2Shan Li (California Institute of Technology)H-Index: 6
Last. Tsui-Fen Chou (California Institute of Technology)H-Index: 22
view all 6 authors...
A major challenge of targeted cancer therapy is the selection for drug‐resistant mutations in tumor cells leading to loss of treatment effectiveness. p97/VCP is a central regulator of protein homeostasis and a promising anti‐cancer target because of its vital role in cell growth and survival. One ATP‐competitive p97 inhibitor, CB‐5083, has entered clinical trials. Selective pressure on HCT116 cells treated with CB‐5083 identified 5 different resistant mutants. Identification of p97 inhibitors wi...
11 CitationsSource
#1Donna M. HurynH-Index: 28
#2David J P KornfiltH-Index: 1
Last. Peter WipfH-Index: 94
view all 3 authors...
The AAA+ ATPase, p97, also referred to as VCP, plays an essential role in cellular homeostasis by regulating endoplasmic reticulum-associated degradation (ERAD), mitochondrial-associated degradation (MAD), chromatin-associated degradation, autophagy, and endosomal trafficking. Mutations in p97 have been linked to a number of neurodegenerative diseases, and overexpression of wild type p97 is observed in numerous cancers. Furthermore, p97 activity has been shown to be essential for the replication...
26 CitationsSource
#1Willem De RidderH-Index: 4
#2Abdelkrim AzmiH-Index: 14
Last. Jonathan BaetsH-Index: 39
view all 13 authors...
Objective To assess the clinical, radiologic, myopathologic, and proteomic findings in a patient manifesting a multisystem proteinopathy due to a homozygous valosin-containing protein gene (VCP) mutation previously reported to be pathogenic in the heterozygous state. Methods We studied a 36-year-old male index patient and his father, both presenting with progressive limb-girdle weakness. Muscle involvement was assessed by MRI and muscle biopsies. We performed whole-exome sequencing and Sanger se...
5 CitationsSource
#1Paige M. Dexter (Duke University)H-Index: 2
#2Ekaterina S. Lobanova (Duke University)H-Index: 12
Last. Vadim Y. Arshavsky (Duke University)H-Index: 54
view all 4 authors...
Abstract Inherited retinal degenerations originate from mutations in >300 genes, many of which cause the production of misfolded mutant photoreceptor proteins that are ultimately degraded by the ubiquitin-proteasome system (UPS). It was previously shown that rod photoreceptors in multiple mouse models of retinal degeneration suffer from proteostatic stress consisting of an insufficient cellular capacity for degrading UPS substrates. In this study, we focused on a specific UPS component required ...
3 CitationsSource
#1Paulina Jakubiak (Hoffmann-La Roche)H-Index: 4
#2Carina Cantrill (Hoffmann-La Roche)H-Index: 2
Last. Rubén Alvarez-Sánchez (Hoffmann-La Roche)H-Index: 14
view all 4 authors...
A large variety of drugs bind effectively to melanin and this binding influences their ocular pharmacokinetic and distribution profiles. We aimed to establish a correlation between in vitro melanin binding and in vivo ocular pharmacokinetics (PK). The extent of melanin binding in vitro was determined for a set of model drugs; binding kinetics and binding isotherms were generated and fitted to a mechanistic model to derive the drug-melanin binding parameters (Bmax, KD, kon and koff). In addition,...
8 CitationsSource
#1Yaoyan Qiu (UM: University of Michigan)H-Index: 3
#2Jingyu Yao (UM: University of Michigan)H-Index: 10
Last. David N. Zacks (UM: University of Michigan)H-Index: 30
view all 5 authors...
The P23H variant of rhodopsin results in misfolding of the protein, and is a common cause of the blinding disease autosomal dominant retinitis pigmentosa (adRP). We have recently demonstrated that degeneration of photoreceptor cells in retinas of P23H mice is due to the endoplasmic reticulum stress (ERS)-induced activation of autophagy that leads to a secondary proteasome insufficiency and activation of cell death pathways. We propose that this increased level of autophagy flux relative to prote...
14 CitationsSource
#1Paul S.-H. Park (Case Western Reserve University)H-Index: 23
Rhodopsin is the light receptor in photoreceptor cells of the retina and a prototypical G protein-coupled receptor. Two types of quaternary structures can be adopted by rhodopsin. If rhodopsin folds and attains a proper tertiary structure, it can then form oligomers and nanodomains within the photoreceptor cell membrane. In contrast, if rhodopsin misfolds, it cannot progress through the biosynthetic pathway and instead will form aggregates that can cause retinal degenerative disease. In this rev...
11 CitationsSource
#1Justin T. Marinko (Vandy: Vanderbilt University)H-Index: 4
#2Hui Huang (Vandy: Vanderbilt University)H-Index: 5
Last. Charles R. Sanders (Vandy: Vanderbilt University)H-Index: 53
view all 6 authors...
Advances over the past 25 years have revealed much about how the structural properties of membranes and associated proteins are linked to the thermodynamics and kinetics of membrane protein (MP) folding. At the same time biochemical progress has outlined how cellular proteostasis networks mediate MP folding and manage misfolding in the cell. When combined with results from genomic sequencing, these studies have established paradigms for how MP folding and misfolding are linked to the molecular e...
85 CitationsSource
#1Wadood Haq (University of Tübingen)H-Index: 6
#2Johannes Dietter (University of Tübingen)H-Index: 7
Last. Eberhart Zrenner (University of Tübingen)H-Index: 85
view all 3 authors...
Electrical (e-) stimulation is explored in schemes to rescue the vision of blind people, e.g. those affected by Retinitis Pigmentosa (RP). We e-activated subretinally the surviving degenerated photoreceptors (d-Phrs) of the rd1 mouse (RP model) and evoked visual responses in the blind retina. The e-stimulation was applied with a single platinum/iridium electrode. The d-Phrs (calcium-imaging) and ganglion cells (GC) activity (MEA-recording) were recorded in simultaneous multilayer recordings. The...
7 CitationsSource
#1Jingyu Yao (UM: University of Michigan)H-Index: 10
#2Yaoyan Qiu (CSU: Central South University)H-Index: 3
Last. David N. Zacks (UM: University of Michigan)H-Index: 30
view all 9 authors...
ABSTRACTMutations in the genes necessary for the structure and function of vertebrate photoreceptor cells are associated with multiple forms of inherited retinal degeneration. Mutations in the gene encoding RHO (rhodopsin) are a common cause of autosomal dominant retinitis pigmentosa (adRP), with the Pro23His variant of RHO resulting in a misfolded protein that activates endoplasmic reticulum stress and the unfolded protein response. Stimulating macroautophagy/autophagy has been proposed as a st...
34 CitationsSource
Cited By4
Newest
#1Merve Sen (University of Tübingen)H-Index: 2
#2Al-Amin (UNIPD: University of Padua)H-Index: 1
Last. Marius Ueffing (University of Tübingen)H-Index: 72
view all 10 authors...
Abstract null null Mutations in rhodopsin lead to its misfolding resulting in autosomal dominant retinitis pigmentosa (adRP). Pharmacological inhibition of the ATP-driven chaperone valosin-containing protein (VCP), a molecular checkpoint for protein quality control, slows down retinal degeneration in animal models. However, poor water-solubility of VCP inhibitors poses a challenge to their clinical translation as intravitreal injections for retinal treatment. In order to enable the delivery of V...
Source
#1Merve Sen (University of Tübingen)H-Index: 2
#2Oksana Kutsyr (University of Alicante)H-Index: 4
Last. Marius Ueffing (University of Tübingen)H-Index: 72
view all 6 authors...
1.Rhodopsin (RHO) misfolding mutations are a common cause of the blinding disease autosomal dominant retinitis pigmentosa (adRP). The most prevalent mutation, RHOP23H, results in its misfolding and retention in the Endoplasmic Reticulum (ER). Under homeostatic conditions, misfolded proteins are selectively identified, retained at the ER, and cleared via ER-associated degradation (ERAD) and/or autophagy. Overload of these degradation processes for a prolonged period leads to imbalanced proteostas...
1 CitationsSource
#1Merve Sen (University of Tübingen)H-Index: 2
#2Al-Amin M (UNIPD: University of Padua)
Last. Marius Ueffing (University of Tübingen)H-Index: 72
view all 10 authors...
1.Mutations in rhodopsin lead to its misfolding resulting in autosomal dominant retinitis pigmentosa (adRP). Pharmacological inhibition of the ATP-driven chaperone valosin- containing protein (VCP), a molecular checkpoint for protein quality control, slows down retinal degeneration in animal models. However, poor water-solubility of VCP inhibitors poses a challenge to their clinical translation as intravitreal injections for retinal treatment. In order to enable the delivery of VCP inhibitors, w...
Source
#1Merve Sen (University of Tübingen)H-Index: 2
#2Marco BassettoH-Index: 1
Last. Blanca Arango-Gonzalez (University of Tübingen)H-Index: 18
view all 6 authors...
The use of synthetic RNA for research purposes as well as RNA-based therapy and vaccination has gained increasing importance. Given the anatomical seclusion of the eye, small interfering RNA (siRNA)-induced gene silencing bears great potential for targeted reduction of pathological gene expression that may allow rational treatment of chronic eye diseases in the future. However, there is yet an unmet need for techniques providing safe and efficient siRNA delivery to the retina. We used magnetic n...
3 CitationsSource